Product ID: SQMIG35H2162
Report ID:
SQMIG35H2162 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
65 |
Figures:
75
In December 2023 to create cellular treatment goods, services, and testing, GenCure and the University of Texas at San Antonio (UTSA) partnered.
A contract for the research, development, and production of iPSC-derived regulatory T cells (Tregs) with potential therapeutic applications was signed in August 2023 by BlueRock Therapeutics LP and bit.bio.
In July 2023, PromoCell GmbH introduced the PromoExQ MSC Growth Medium XF, which enables the consistent growth and maintenance of multipotent human mesenchymal stem cells (hMSCs) in vitro within a controlled environment.
Pluristyx, Inc. and Stem Genomics collaborated in July 2023. Through this collaboration, the Stem Genomics iCS-digital PSC assay will be used to assess the genomic stability of Pluristyx's pluripotent stem cell (PSC) lines.
June of 2023 The human induced pluripotent stem cell (iPSC) producer, FUJIFILM Cellular Dynamics, has announced the release of their iCell Blood-Brain Barrier Isogenic Kit, designed for scientists who are involved in the drug development process for neuroactive pharmaceuticals. The kit can improve medication development, discovery, and medical research for disorders of the central nervous system (CNS) since it maintains barrier integrity.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35H2162